Korean Drug Ministry releases more biosimilar approval results in English - (The Korea Herald via NewsPoints Desk)

  • South Korea's food and drug safety ministry released English versions of approvals for several biosimilars, The Korea Herald reported Wednesday.

  • The ministry approved Samsung Bioepis' Brenzys, a biosimilar of Amgen's Enbrel, and Renflexis, a biosmilar of Johnson & Johnson's Remicade.

  • Earlier this year, the food and drug safety ministry unveiled English-language approvals for Celltron's Remicade biosimilar Remsima and Herzuma, a biosimilar of Roche's Herceptin.

  • Other approvals slated for disclosure in English include Celltrion's Trumixa, a biosimilar of Roche's Rituxan, following its authorisation in November.

  • "We will continue to open up the results of our approval evaluation of Korean biosimilars to aid the launch of the drugs in global markets," the ministry explained.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.